CUBIST PHARMACEUTICALS INC - FORM 10-K - EX-32.2 - EXHIBIT 32.2 - February 26, 2010

Attached files

file filename
10-K - 10-K - CUBIST PHARMACEUTICALS INCa2196647z10-k.htm
EX-2.2 - EXHIBIT 2.2 - CUBIST PHARMACEUTICALS INCa2196647zex-2_2.htm
EX-10.31 - EXHIBIT 10.31 - CUBIST PHARMACEUTICALS INCa2196647zex-10_31.htm
EX-23.2 - EXHIBIT 23.2 - CUBIST PHARMACEUTICALS INCa2196647zex-23_2.htm
EX-21.1 - EXHIBIT 21.1 - CUBIST PHARMACEUTICALS INCa2196647zex-21_1.htm
EX-31.2 - EXHIBIT 31.2 - CUBIST PHARMACEUTICALS INCa2196647zex-31_2.htm
EX-23.1 - EXHIBIT 23.1 - CUBIST PHARMACEUTICALS INCa2196647zex-23_1.htm
EX-32.1 - EXHIBIT 32.1 - CUBIST PHARMACEUTICALS INCa2196647zex-32_1.htm
EX-31.1 - EXHIBIT 31.1 - CUBIST PHARMACEUTICALS INCa2196647zex-31_1.htm
EX-10.60 - EXHIBIT 10.60 - CUBIST PHARMACEUTICALS INCa2196647zex-10_60.htm
EX-10.57 - EXHIBIT 10.57 - CUBIST PHARMACEUTICALS INCa2196647zex-10_57.htm
EX-10.58 - EXHIBIT 10.58 - CUBIST PHARMACEUTICALS INCa2196647zex-10_58.htm
EX-10.61 - EXHIBIT 10.61 - CUBIST PHARMACEUTICALS INCa2196647zex-10_61.htm
EX-10.52 - EXHIBIT 10.52 - CUBIST PHARMACEUTICALS INCa2196647zex-10_52.htm
EX-10.56 - EXHIBIT 10.56 - CUBIST PHARMACEUTICALS INCa2196647zex-10_56.htm
EX-10.47 - EXHIBIT 10.47 - CUBIST PHARMACEUTICALS INCa2196647zex-10_47.htm
EX-10.54 - EXHIBIT 10.54 - CUBIST PHARMACEUTICALS INCa2196647zex-10_54.htm
EX-10.51 - EXHIBIT 10.51 - CUBIST PHARMACEUTICALS INCa2196647zex-10_51.htm
EX-10.59 - EXHIBIT 10.59 - CUBIST PHARMACEUTICALS INCa2196647zex-10_59.htm
EX-10.33 - EXHIBIT 10.33 - CUBIST PHARMACEUTICALS INCa2196647zex-10_33.htm
EX-10.55 - EXHIBIT 10.55 - CUBIST PHARMACEUTICALS INCa2196647zex-10_55.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002

        In connection with the Annual Report of Cubist Pharmaceuticals, Inc. ("Cubist") on Form 10-K for the period ending December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, David W.J. McGirr, Chief Financial Officer of Cubist, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Cubist.

February 26, 2010

/s/ DAVID W.J. MCGIRR
 David W.J. McGirr
 Senior Vice President and
Chief Financial Officer		    



QuickLinks

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Stock widget

Investing forum

CUBIST PHARMACEUTICALS INC Reports